ClinVar Miner

Submissions for variant NM_001110792.2(MECP2):c.1173dup (p.Val392fs)

dbSNP: rs1557135793
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mayo Clinic Laboratories, Mayo Clinic RCV000660654 SCV000782782 pathogenic Rett syndrome 2018-02-12 criteria provided, single submitter clinical testing
Invitae RCV000702922 SCV000831799 pathogenic Severe neonatal-onset encephalopathy with microcephaly 2022-12-06 criteria provided, single submitter clinical testing For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the MECP2 protein in which other variant(s) (p.Pro389*, p.Leu386Hisfs*5) have been determined to be pathogenic (PMID: 16473305, 19914908). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 548031). This variant has not been reported in the literature in individuals affected with MECP2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val380Argfs*13) in the MECP2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 107 amino acid(s) of the MECP2 protein.
GeneDx RCV001009240 SCV001169061 pathogenic not provided 2019-08-14 criteria provided, single submitter clinical testing The c.1137dupC variant in the MECP2 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.1137dupC variant causes a frameshift starting with codon Valine 380, changes this amino acid to an Arginine residue, and creates a premature Stop codon at position 13 of the new reading frame, denoted p.Val380ArgfsX13. This variant is predicted to cause loss of normal protein function through protein truncation. The c.1137dupC variant is not observed in large population cohorts (Lek et al., 2016). We interpret c.1137dupC as a pathogenic variant.
Mendelics RCV002249391 SCV002517593 pathogenic X-linked intellectual disability-psychosis-macroorchidism syndrome 2022-05-04 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.